Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patients
Abstract To evaluate the clinical efficacy and safety of transvaginal natural orifice transluminal endoscopic surgery (vNOTES) for treating benign ovarian tumors in obese patients. A retrospective analysis was conducted on the clinical data of 35 obese patients who underwent vNOTES for benign ovaria...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-88599-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823862325470298112 |
---|---|
author | Fei Wang Yuqin Liu Yue Xing Dongdong Wang Xue Bai Linlin Li Chunhua Ma Yongjuan Sun Yufang Bai Liehong Wang |
author_facet | Fei Wang Yuqin Liu Yue Xing Dongdong Wang Xue Bai Linlin Li Chunhua Ma Yongjuan Sun Yufang Bai Liehong Wang |
author_sort | Fei Wang |
collection | DOAJ |
description | Abstract To evaluate the clinical efficacy and safety of transvaginal natural orifice transluminal endoscopic surgery (vNOTES) for treating benign ovarian tumors in obese patients. A retrospective analysis was conducted on the clinical data of 35 obese patients who underwent vNOTES for benign ovarian tumor resection and 41 obese patients who underwent multi-port laparoscopic surgery (MPLS) during the same period from January 2021 to June 2024 at Qinghai Red Cross Hospital. Key parameters such as operative time, intraoperative blood loss, intraoperative and postoperative complications, hospitalization duration, postoperative anal exhaust time, postoperative visual analog scale (VAS) score, and SF-36 score were analyzed. No statistical differences were observed between the two groups regarding baseline characteristics such as age, body mass index (BMI), tumor diameter, parity, and history of pelvic surgery. The vNOTES group exhibited shorter operative times compared to the MPLS group, with no significant differences in tumor pathology, intraoperative blood loss, or tumor rupture rates. Postoperatively, the vNOTES group had shorter hospital stays, fewer postoperative complications, lower 24-hour postoperative VAS scores, and higher three-month postoperative SF-36 scores compared to the MPLS group. No differences were found between the groups concerning anal exhaust time, sexual satisfaction rate, or 24-hour postoperative VAS scores. vNOTES is a safe and feasible surgical method for treating benign ovarian tumors in obese patients, offering advantages such as no abdominal incisions and quicker postoperative recovery. |
format | Article |
id | doaj-art-a177d641dfbf401284b0413bc544b09e |
institution | Kabale University |
issn | 2045-2322 |
language | English |
publishDate | 2025-02-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Scientific Reports |
spelling | doaj-art-a177d641dfbf401284b0413bc544b09e2025-02-09T12:35:01ZengNature PortfolioScientific Reports2045-23222025-02-011511610.1038/s41598-025-88599-9Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patientsFei Wang0Yuqin Liu1Yue Xing2Dongdong Wang3Xue Bai4Linlin Li5Chunhua Ma6Yongjuan Sun7Yufang Bai8Liehong Wang9School of Clinical Medicine, Qinghai UniversityDepartment of Gynaecology and Obstetrics, Qinghai Red Cross HospitalDepartment of Gynaecology and Obstetrics, Qinghai Red Cross HospitalSchool of Clinical Medicine, Qinghai UniversityDepartment of Gynaecology and Obstetrics, Qinghai Red Cross HospitalDepartment of Gynaecology and Obstetrics, Qinghai Red Cross HospitalDepartment of Gynaecology and Obstetrics, Qinghai Red Cross HospitalDepartment of Gynaecology and Obstetrics, Qinghai Red Cross HospitalSchool of Clinical Medicine, Qinghai UniversitySchool of Clinical Medicine, Qinghai UniversityAbstract To evaluate the clinical efficacy and safety of transvaginal natural orifice transluminal endoscopic surgery (vNOTES) for treating benign ovarian tumors in obese patients. A retrospective analysis was conducted on the clinical data of 35 obese patients who underwent vNOTES for benign ovarian tumor resection and 41 obese patients who underwent multi-port laparoscopic surgery (MPLS) during the same period from January 2021 to June 2024 at Qinghai Red Cross Hospital. Key parameters such as operative time, intraoperative blood loss, intraoperative and postoperative complications, hospitalization duration, postoperative anal exhaust time, postoperative visual analog scale (VAS) score, and SF-36 score were analyzed. No statistical differences were observed between the two groups regarding baseline characteristics such as age, body mass index (BMI), tumor diameter, parity, and history of pelvic surgery. The vNOTES group exhibited shorter operative times compared to the MPLS group, with no significant differences in tumor pathology, intraoperative blood loss, or tumor rupture rates. Postoperatively, the vNOTES group had shorter hospital stays, fewer postoperative complications, lower 24-hour postoperative VAS scores, and higher three-month postoperative SF-36 scores compared to the MPLS group. No differences were found between the groups concerning anal exhaust time, sexual satisfaction rate, or 24-hour postoperative VAS scores. vNOTES is a safe and feasible surgical method for treating benign ovarian tumors in obese patients, offering advantages such as no abdominal incisions and quicker postoperative recovery.https://doi.org/10.1038/s41598-025-88599-9vNOTESObesityBenign ovarian tumorClinical efficacyRetrospective analysis |
spellingShingle | Fei Wang Yuqin Liu Yue Xing Dongdong Wang Xue Bai Linlin Li Chunhua Ma Yongjuan Sun Yufang Bai Liehong Wang Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patients Scientific Reports vNOTES Obesity Benign ovarian tumor Clinical efficacy Retrospective analysis |
title | Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patients |
title_full | Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patients |
title_fullStr | Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patients |
title_full_unstemmed | Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patients |
title_short | Clinical efficacy and safety study of vNOTES for benign ovarian tumors in obese patients |
title_sort | clinical efficacy and safety study of vnotes for benign ovarian tumors in obese patients |
topic | vNOTES Obesity Benign ovarian tumor Clinical efficacy Retrospective analysis |
url | https://doi.org/10.1038/s41598-025-88599-9 |
work_keys_str_mv | AT feiwang clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients AT yuqinliu clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients AT yuexing clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients AT dongdongwang clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients AT xuebai clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients AT linlinli clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients AT chunhuama clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients AT yongjuansun clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients AT yufangbai clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients AT liehongwang clinicalefficacyandsafetystudyofvnotesforbenignovariantumorsinobesepatients |